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Table I. Preoperative/intraoperative variables associated with ischemic
colitis in open abdominal aortic aneurysm repair
Risk factors AOR 95% CI P
Female gender vs male gender 3.07 1.15-8.18 .025
Suprarenal clamping vs infrarenal clamping 2.67 1.02-7.02 .046
Ruptured aneurysm vs nonruptured aneurysm 3.96 1.43-10.97 .08
Operation time 1.001 0.9-1.00 .64
Chronic renal failure vs no comorbidity 5.49 0.48-62.66 .17
Age 0.99 0.99-1.005 .79
Need for intra/postoperative transfusion 2.06 0.44-9.58 .35
AOR, Adjusted odds ratio; CI, conﬁdence interval.
Table II. Preoperative/Intraoperative variables associated with ischemic
colitis in endovascular aneurysm repair
Risk factors AOR 95% CI P
Ruptured aneurysm vs non-ruptured aneurysm 7.61 2.44-23.66 <.001
Need for intra/postoperative transfusion 6.91 1.76-27.09 .006
Female gender vs male gender 1.56 0.50-4.86 .43
Operation time 1.001 0.99-1.006 .85
Chronic renal failure vs no comorbidity 5.14 0.84-31.28 .07
Age 1.01 0.95-1.06 .73
AOR, Adjusted odds ratio; CI, conﬁdence interval.
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Objective: Physician-modiﬁed endovascular grafts, with fenestrations
added to accommodate major branch vessels, provide a means for endovas-
cular treatment of abdominal aortic aneurysms (AAAs) that are adjacent to
the renal arteries. Manual measurements of vessel origin locations from
computed tomography (CT) images, however, take time and can lead to er-
rors in the positions of the fenestrations. This is especially true for angulated
aortic neck anatomy. To make the fenestration process faster and more ac-
curate, we have developed a procedure to create custom templates that serve
as patient-speciﬁc guides for graft fenestration.
Methods: We use custom proprietary software to outline the aorta in
a patient’s CT image data set and create a three-dimensional (3D) computer
model of the lumen and the branch vessel origins (Fig, A). A clear rigid
sleeve is then produced with a 3D printer that includes holes at the locations
of the branch vessels (Fig, B). The sleeve is sterilized and slipped over the
graft at the time of the operative procedure, and it can be rotated to avoid
positioning the holes over stent struts (Fig, C). The locations of the
openings are marked with a sterile pen, and the fenestrations are created
after the sleeve is removed. Our template-based fenestration procedure was
validated using an aorta phantom in which we deployed a fenestrated graft.
The phantom was created by embedding a commercially available ﬂexible
AAA model in an agar block. The aorta phantom was scanned by CT, and a
template was designed and printed to match the four branch vessels
included in the phantom. Fenestrations were created in a standard graft
using the custom template, and the alignment of the fenestrations with the
branch vessels was evaluated by ﬂuoroscopy.
Results: Continuous ﬂuoroscopy of the aorta phantom showed
proper alignment of the graft fenestrations with the 4 branch vessel origins
after deployment of the modiﬁed graft. The 3D printing method has also
been demonstrated by creating templates from clinical CT images of three
patients with juxtarenal AAAs.
Conclusions: Custom fenestration templates provide for fast and ac-
curate placement of all fenestrations, without the need for manual measure-
ments. Graft fenestration using custom templates will likely save procedural
costs and make minimally invasive aneurysm repair available to more pa-
tients with challenging anatomy.
Fig. Three-dimensional-printed template for graft fenestration.
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Risk Factors and Outcomes of Postoperative Ischemic Colitis in
Contemporary Open and Endovascular Abdominal Aortic Aneurysm
Repair
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Objectives: Postoperative ischemic colitis (IC) can be a serious
complication after infrarenal abdominal aortic aneurysm (AAA) repair. We
sought to identify risk factors and outcomes in patients developing IC after
open and endovascular AAA repair (EVAR).Methods: The NSQIP database was used to examine clinical data of
patients undergoing AAA repair from 2011 to 2012 who developed postop-
erative IC. Multivariate regression analysis was performed to identify risk
factors and outcomes.
Results: We evaluated a cohort of 3486 patients who underwent AAA
repair (11.6% open repair and 88.4% EVAR). The incidence of postopera-
tive IC was 2.2% (5.2% for open repair and 1.8% for EVAR). Surgical treat-
ment was needed in 49.3% of patients. The mortality of patients with IC was
higher than patients without IC (adjusted odds ratio (AOR), 4.78; P < .01).
Also, the need for surgical treatment (AOR, 6.20) and age (AOR, 1.07)
were mortality predictors of IC patients. Predictive factors of IC included
(P < .05) female gender (AOR, 2.27), chronic renal failure (AOR, 5.75),
need for intraoperative/postoperative transfusion (AOR, 5.50), and rupture
of the aneurysm before surgery (AOR, 5.38). Open AAA repair was not an
independent risk factor of IC (AOR, 1.40, P ¼ .39), and the higher IC rate
in open AAA repair compared with EVAR was related to the higher need for
transfusion in open AAA repair (AOR, 10.67). Also, in open AAA repair,
suprarenal clamping of the aorta (AOR, 2.76) was a predictor of IC. Suba-
nalysis of the data in both groups is reported in Tables I and II.
Conclusions: Although the frequency of IC in open AAA repair was
nearly three times greater than in EVAR, open surgery is not an indepen-
dent predictor of IC. Rupture of the aneurysm before surgery, suprarenal
clamping of the aorta, need for transfusion, and chronic renal failure are
postoperative IC predictors. AAA patients who develop IC have a nearly
ﬁvefold higher mortality compared with those without IC. Surgical treat-
ment is needed in nearly 50% of IC patients and is a mortality predictor.Author Disclosures: Z. Moghadamyeghaneh: None; MD Sgroi: None;
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Relative Oxygen Indices in the Foot of Patients with Critical Limb
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Objective: Critical limb ischemia (CLI) patients exhibit uneven pat-
terns of perfusion in the foot, which makes it challenging to determine
adequate topographic needs by angiography alone. This study assessed
the feasibility of reporting dynamic relative oxygen indices from multiple lo-
cations on the foot during endovascular therapy, using a novel micro-oxy-
gen sensor (MOXYs) approach.
Methods: A prospective, 28-day, single-arm, observational study was
performed on 10 patients who underwent endovascular therapy for CLI. At
least 24 hours before therapy, four MOXYs were injected in each patient,
one in the arm and three in the treated foot. The optical signal from the
MOXYs corresponds to relative oxygen concentration. A custom detector
on the surface of the skin was used to continuously and noninvasively
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injected MOXY was characterized. Oxygen data from the MOXYs were
collected throughout the revascularization procedure. The timing of ther-
apy deployment was recorded during the procedure to assess its relationship
with the oxygen data from the MOXYs. Moreover, oxygen data collection
and clinical evaluation were performed immediately postoperatively as well
as on postoperative days 7, 14, 21, and 28. The study protocol was
approved by the CEATE Research Foundation IRB of Costa Rica; informed
consent was obtained from patients before study procedures.
Results: Ten CLI patients (50% male) were enrolled (30% class 4,
70% class 5), and the mean age was 70.7 years (range, 46-90 years). All pa-
tients were Hispanic of varying origins (European and indigenous origins).
MOXYs were successfully read 209 of 212 times (98.6%) in all patients dur-
ing the course of the study. Sensors were compatible with intraoperative use
in the catheterization laboratory and postoperative use in an ofﬁce setting.
In nine of 10 revascularization procedures, at least one of the three MOXYs
showed immediate change in dynamic relative oxygen indices, correlating to
deployed therapy (Fig). There were no adverse events related to the
microsensor materials.
Conclusions: The study results show that use of MOXYs in CLI
merits further testing to determine its potential effect on clinical decision
making that ultimately can lead to improved healing and limb salvage rates.
Fig. An Example of Dynamic Relative Oxygen Indices (DROIDS) versus
Time during endovascular therapy showing the effect of delivered therapy
on local perfusion on the foot.
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More Aggressive Anticoagulation/Antiplatelet Regimen Improves
Patency Following Viabahn Stent Grafting of the SFA
Brant W. Ullery, MD, Nathan Itoga, MD, Kenneth Tran, Ronald L.
Dalman, MD, Jason T. Lee, MD. Stanford University, Stanford, Calif
Objective: Covered stents are increasingly used to treat femoropopli-
teal occlusive disease. We aimed to determine which clinical variables and
postprocedural pharmacologic regimen provided optimal long-term graft
patency.
Methods: Clinical and angiographic data for consecutive patients
from 2006 to 2012 undergoing superﬁcial femoral artery (SFA) stenting
with Viabahn covered stent grafts were reviewed. Graft patency was deﬁned
as uninterrupted freedom from restenosis or occlusion and was determined
by Kaplan-Meier analysis. The inﬂuence of relevant clinical variables on
patency was determined via univariate and multivariate analyses.
Results: Viabahn stent grafts were placed in 85 limbs in 65 patients
(65% male; mean age, 70 years). Indication for treatment included claudica-
tion (n ¼ 54) or critical limb ischemia (n ¼ 31), with the majority classiﬁed
as TASC II C (n ¼ 30) or D (n ¼ 30) lesions. Mean follow-up was 34
months (range, 12-80 months). Postprocedural pharmacologic regimens
included acetylsalicylic acid (ASA), clopidogrel, and warfarin (49%), ASA
and permanent clopidogrel (44%), or ASA and temporary clopidogrel
(7%). Primary patency rates at 1, 2, and 3 years were 49%, 25%, and 17%,respectively. Secondary patency rates at 1, 2, and 3 years were 69%, 43%,
and 31%, respectively. Multivariate analysis identiﬁed use of 5-mm stents
(hazard ratio, 1.56) as an independent risk factor for loss of patency.
Kaplan-Meier analysis demonstrated signiﬁcantly shorter mean primary
patency among TASC D lesions (17.9 months vs TASC C, 22.4 months
vs TASC A+B, 35.8 months; P ¼ .02) and those taking ASA + temporary
clopidogrel (6.4 months vs ASA + permanent clopidogrel, 24.9 months vs
ASA + clopidogrel + warfarin, 26.9 months; P ¼ .018; Figs 1 and 2).
Eighty-three percent of patients discontinuing clopidogrel within 3 months
of the procedure exhibited loss of primary patency.
Conclusions: Smaller stent size (<6 mm) independently predicted
loss of primary patency. Improved primary patency rates were noted with
non-TASC D lesions and aggressive antiplatelet/anticoagulation regimens.
Patients undergoing SFA stent grafting for occlusive disease should receive
$6-mm-diameter stents and be maintained on clopidogrel for a minimum
of 6 months postprocedure, and potentially lifelong if tolerated.
Fig 1. Primary patency by TASC II classiﬁcation.
Fig 2. Primary patency by pharmacologic regimen.
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Objective: Registries are proven useful to assess clinical outcomes, but
data entry and personnel expenses are a challenge. We developed a registry
to track patients undergoing endovascular aortic aneurysm repair (EVAR) in
an integrated health care system leveraging an electronic medical record
(EMR) to evaluate clinical practices, device performance, surgical
